WO2004108125A1 - Agent d'inactivation de coronavirus - Google Patents
Agent d'inactivation de coronavirus Download PDFInfo
- Publication number
- WO2004108125A1 WO2004108125A1 PCT/RU2004/000215 RU2004000215W WO2004108125A1 WO 2004108125 A1 WO2004108125 A1 WO 2004108125A1 RU 2004000215 W RU2004000215 W RU 2004000215W WO 2004108125 A1 WO2004108125 A1 WO 2004108125A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- inactivating agent
- miramistin
- results
- coronavirus inactivating
- coronavirus
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Definitions
- Iz ⁇ b ⁇ e ⁇ enie ⁇ n ⁇ si ⁇ sya ⁇ ⁇ blas ⁇ i meditsshsh and ⁇ a ⁇ matsev ⁇ iches ⁇ y ⁇ myishenn ⁇ s ⁇ i and m ⁇ zhe ⁇ by ⁇ is ⁇ lz ⁇ van ⁇ in s ⁇ zdanii, ya ⁇ izv ⁇ ds ⁇ ve and ⁇ imenenii dechebny ⁇ and ⁇ ila ⁇ iches ⁇ i ⁇ ⁇ e ⁇ a ⁇ a ⁇ v.
- Sheboldov // The Navigation of People and Animals, ⁇ .. Meditsina, 1977.-.e. 221; General and private virology, ed. ⁇ . ⁇ . Zhdanova, p.5 ⁇ . Haidamovich. 1982, ⁇ ., ⁇ edischgaa, ⁇ .2, p. 316-339; ⁇ .Y. ⁇ réellenoc, S. ⁇ . Babichev // Medical Medicine, Virology and Immunology, St. Russia: “Special Literature”. 1998 - p. 273).
- Proposed use of a medicament for the purchase of accidents of minerals is an indispensable disease.
- syphidis, trichomoniasis, gonorrhea and also used as an ophthalmic antasptic (Patent No. 2164135) as well as virulent eye disease.
- miramistin is at risk of the inactivation of known and known pharmaceutical substances.
- the analysis of the obtained data shows that miramistin in the concentration of 0.0001% reduces the infectious activity of the human invoicing factor by two times, and in it is more than 5%.
- ⁇ Cultural liquid containing a ⁇ C43 blood vessel with a hemagglutinating rate of at least 1: 512 added an increase of miramistin in a concentration of 0.000001 to 0.001%.
- the mixture was incubated for 30 minutes, added 25% of embryo food for neutralization of miramistin, kept for 10-20 minutes and then set to
- Miramistin as a part of the remedy for inactivating and on its basis to create new medical and therapeutic measures for dealing with illnesses.
Description
Claims
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP04748924A EP1634590A4 (en) | 2003-06-04 | 2004-06-03 | CORONAVIRUS INACTIVATION AGENT |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2003116391/15A RU2234313C1 (ru) | 2003-06-04 | 2003-06-04 | Средство инактивации коронавирусов |
RU2003116391 | 2003-06-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004108125A1 true WO2004108125A1 (fr) | 2004-12-16 |
Family
ID=33414532
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/RU2004/000215 WO2004108125A1 (fr) | 2003-06-04 | 2004-06-03 | Agent d'inactivation de coronavirus |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1634590A4 (ru) |
KR (1) | KR20060054190A (ru) |
CN (1) | CN100350904C (ru) |
RU (1) | RU2234313C1 (ru) |
WO (1) | WO2004108125A1 (ru) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021176010A1 (en) | 2020-03-05 | 2021-09-10 | Ecosynth Nv | Antiviral treatment |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008039254A1 (de) * | 2008-08-20 | 2010-02-25 | Megainpharm Gmbh | Arzneimittel |
WO2011100994A1 (de) | 2010-02-19 | 2011-08-25 | Megainpharm Gmbh | Arzneimittel enthaltend myramistin |
WO2014175757A1 (ru) | 2013-04-22 | 2014-10-30 | Общество с ограниченной ответственностью "Нанобиотех" | Антисептический ветеринарный препарат и способы его использования |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2459062A (en) * | 1944-02-08 | 1949-01-11 | American Cyanamid Co | Quaternary ammonium compounds |
SU1796185A1 (ru) * | 1990-06-23 | 1993-02-23 | Adolina P Rudko | Фунгицид 2 |
US5244922A (en) * | 1990-09-04 | 1993-09-14 | Burzynski Stanislaw R | Methods for treating viral infections |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2493792A (en) * | 1991-07-10 | 1993-02-11 | Jury Semenovich Krivoshein | Pharmaceutical preparation |
-
2003
- 2003-06-04 RU RU2003116391/15A patent/RU2234313C1/ru not_active IP Right Cessation
-
2004
- 2004-06-03 CN CNB200480015086XA patent/CN100350904C/zh not_active Expired - Fee Related
- 2004-06-03 EP EP04748924A patent/EP1634590A4/en not_active Withdrawn
- 2004-06-03 WO PCT/RU2004/000215 patent/WO2004108125A1/ru active Application Filing
- 2004-06-03 KR KR1020057023103A patent/KR20060054190A/ko not_active Application Discontinuation
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2459062A (en) * | 1944-02-08 | 1949-01-11 | American Cyanamid Co | Quaternary ammonium compounds |
SU1796185A1 (ru) * | 1990-06-23 | 1993-02-23 | Adolina P Rudko | Фунгицид 2 |
US5244922A (en) * | 1990-09-04 | 1993-09-14 | Burzynski Stanislaw R | Methods for treating viral infections |
Non-Patent Citations (3)
Title |
---|
SAKNIMIT M. ET AL.: "Virucidal efficacy of physico-chemical treatments against coronaviruses and parvoviruses of laboratory animals", JIKKEN DOBUTSU, vol. 37, no. 3, July 1988 (1988-07-01), pages 341 - 345, XP008102472 * |
See also references of EP1634590A4 * |
WOOD A. ET AL.: "The action of three antiseptic/disinfectants against enveloped and nonenveloped viruses", J. HOSP. INFECT., vol. 38, no. 4, April 1998 (1998-04-01), pages 283 - 295, XP008102368 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2021176010A1 (en) | 2020-03-05 | 2021-09-10 | Ecosynth Nv | Antiviral treatment |
Also Published As
Publication number | Publication date |
---|---|
EP1634590A4 (en) | 2009-04-08 |
CN1798553A (zh) | 2006-07-05 |
RU2234313C1 (ru) | 2004-08-20 |
CN100350904C (zh) | 2007-11-28 |
KR20060054190A (ko) | 2006-05-22 |
EP1634590A1 (de) | 2006-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU94002475A (ru) | Фармацевтическая композиция и ее применение для лечения вирусных инфекций | |
Shah et al. | Adjuvant combined ozone therapy for extensive wound over tibia | |
US20080195033A1 (en) | Method of Delivery of Therapeutic Metal Ions, Alloys and Salts | |
KR20200024187A (ko) | 라이노 바이러스의 치료 또는 경감을 위한 항바이러스제 | |
KR20170033925A (ko) | 항바이러스 및 세균용 스프레이 조성물 | |
RU2150281C1 (ru) | Способ лечения респираторных болезней телят | |
WO2004108125A1 (fr) | Agent d'inactivation de coronavirus | |
RU2665959C1 (ru) | Спрей для экстренной профилактики острых респираторных вирусных инфекций | |
RU2502512C2 (ru) | Способ лечения гриппа птиц | |
US20060287364A1 (en) | Methods of prevention of infection with HIV/AIDS, venereal disease and influenza | |
RU2480219C1 (ru) | Способ лечения оспы | |
WO2015002576A1 (ru) | Применение адсорбированного гомогената трутневого расплода и витамина d3 или витаминов группы d и/или их активных метаболитов для профилактики и лечения вирусных заболеваний | |
Derry | Iodine: the forgotten weapon against influenza viruses | |
RU2742341C1 (ru) | Способ лечения хронического генерализованного пародонтита | |
RU2762506C1 (ru) | Средство для аппликации полости рта и носа и способ его применения в составе комплексной терапии инфекционно-воспалительных заболеваний носовой и ротовой полости | |
RU2753609C1 (ru) | Противовирусное гуминовое средство | |
CN111228247B (zh) | 一种用于治疗包虫病的含苯亚甲基丙酮药物及其制备方法 | |
Gottardi et al. | Thoughts and Questions Arising upon the Recognition of the broadly bioactive and very well tolerated Antiseptic N-Chlorotaureine as a highly useful medicant for prophylaxis and therapy, Herald of the international Academy of Science (Russian Section) | |
Pilania et al. | Ozone therapy–a milestone in dentistry; a review | |
WO2021222291A1 (en) | Pharmaceutical composition comprising chlorine dioxide for the treatment of covid-19 | |
Miranda-Massari et al. | Iodine Oropharyngeal Solution for COVID19: A Cohort Study | |
US9408883B2 (en) | Essential oil of Kunzea ambigua and methods of use | |
Clyde et al. | Therapeutic trials of chloroquine silicate in Tanganyika | |
Ezeibe et al. | In vivo antiretroviral effects of the Medicinal synthetic Aluminum-magnesium silicate | |
UA58059A (ru) | Способ профилактики гриппа |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 1200501779 Country of ref document: VN |
|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2004815086X Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1020057023103 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: 6851/DELNP/2005 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2004748924 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2004748924 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1020057023103 Country of ref document: KR |